Palmer Ashleigh
- SEC CIK
- 0001493714
No open-market purchases or sales filed in the past year.
Current role at each company
- PRVB Provention Bio, Inc.Director and CEOas of Apr 27, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Palmer Ashleigh as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2023 (view filing) | Feb 10-13 | 4 days | Palmer AshleighDirector and CEO | SSale | −75.8K | $10.09 | −$764.9K | −2.9%2.57M after | 2 lots |
| Jan 20, 2023 (view filing) | Jan 18 | 2 days | Palmer AshleighDirector and CEO | SSale | −24.2K | $10.27 | −$248.2K | −0.9%2.57M after | |
| Dec 1, 2021 (view filing) | Nov 30 | 1 day | Palmer AshleighDirector and CEO | PPurchase | +3.75K | $6.66 | +$25.0K | +0.1%2.57M after |